Table 2.

EPVS burden and neuropathologic findings.

	EPVS burden
	Mild or None	Moderate	Severe
N (%)	311 (48)	170 (26)	173 (26)
Gross infarcts, n (%)	109 (35)	83 (49)	85 (49)
Microscopic infarcts, n (%)	97 (31)	65 (38)	72 (41)
Atherosclerosis, n (%)
Severe	21 (7)	9 (5)	12 (7)
Moderate	53 (17)	38 (22)	34 (20)
Mild	166 (53)	79 (47)	92 (53)
Arteriolosclerosis, n (%)
Severe	18 (6)	14 (8)	12 (7)
Moderate	69 (22)	36 (21)	34 (20)
Mild	113 (36)	73 (43)	76 (44)
Cerebral amyloid angiopathy, n (%)
Severe	37 (12)	12 (7)	26 (15)
Moderate	74 (24)	41 (24)	42 (24)
Mild	137 (44)	85 (50)	69 (40)
NIA Reagan (Likelihood of AD), n (%)
High or intermediate	218 (70)	124 (73)	121 (70)
Amyloid plaques, mean (SD)	0.86 (0.66)	0.84 (0.63)	0.85 (0.62)
Neurofibrilary tangles, mean (SD)	0.80 (0.87)	0.78 (0.89)	0.70 (0.84)
Lewy Bodies, n (%)	90 (29)	45 (27)	54 (31)
Hippocampal sclerosis, n (%)	46 (15)	18 (11)	13 (8)
TDP-43 pathology, n (%)
Inclusions in amygdala, entorhinal cortex or hippocampus CA1, and neocortex	60 (19)	25 (15)	22 (13)
Inclusions in amygdala, and entorhinal cortex or hippocampus CA1	67 (22)	33 (19)	37 (21)
Inclusions in amygdala only	51 (16)	40 (24)	25 (14)